Pharma Mar, S.A. (OTCMKTS:PHMMF – Get Free Report) shares traded up 17.7% during trading on Monday . The company traded as high as $88.24 and last traded at $88.24. 4,000 shares were traded during trading, an increase of 725% from the average session volume of 485 shares. The stock had previously closed at $75.00.
Pharma Mar Trading Up 17.7 %
The business’s 50 day moving average is $79.25 and its two-hundred day moving average is $60.13. The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.14.
About Pharma Mar
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Read More
- Five stocks we like better than Pharma Mar
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Sizing Up a New Opportunity for NVIDIA Investors
- 3 Dividend Kings To Consider
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
